{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:20:40Z","timestamp":1789852840466,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s10067-009-1370-1","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T06:07:32Z","timestamp":1265609252000},"page":"563-566","source":"Crossref","is-referenced-by-count":69,"title":["Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature"],"prefix":"10.1007","volume":"29","author":[{"given":"Yuki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoichiro","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneyo","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"1370_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/s10165-004-0275-8","volume":"14","author":"L Weaver","year":"2004","unstructured":"Weaver L (2004) Efficacy and safety of the anti-TNF biologic agents. Mod Rheumatol 14:101\u2013112","journal-title":"Mod Rheumatol"},{"issue":"3","key":"1370_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08916930600622256","volume":"39","author":"S Salomonsson","year":"2006","unstructured":"Salomonsson S, Lundberg IE (2006) Cytokines in idiopathic inflammatory myopathies. Autoimmunity 39(3):177\u2013190","journal-title":"Autoimmunity"},{"key":"1370_CR3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/rheumatology\/keh079","volume":"43","author":"I Labioche","year":"2004","unstructured":"Labioche I, Liozon E, Weschler B, Loustaud-Ratti V, Soria P, Vidal E (2004) Refractory polymyositis responding to infliximab: extended follow-up [letter]. Rheumatology (Oxford) 43:531\u2013532","journal-title":"Rheumatology (Oxford)"},{"key":"1370_CR4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/keh285","volume":"43","author":"A Selva-O\u2019Callaghan","year":"2004","unstructured":"Selva-O\u2019Callaghan A, Martinez-Costa X, Solans-Laque R, Mauri M, Capdevila JA, Vilardell-Tarres M (2004) Refractory adult dermatomyositis with pneumatosis cystoides intestinalis with infliximab [letter]. Rheumatology (Oxford) 43:1196\u20131197","journal-title":"Rheumatology (Oxford)"},{"key":"1370_CR5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/rheumatology\/keh268","volume":"43","author":"I Uthman","year":"2004","unstructured":"Uthman I, El-Sayad J (2004) Refractory polymyositis responding to infliximab [letter]. Rheumatology (Oxford) 43:1198","journal-title":"Rheumatology (Oxford)"},{"key":"1370_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00002281-200405000-00006","volume":"16","author":"AK Imperato","year":"2004","unstructured":"Imperato AK, Smiles S, Abramson SB (2004) Long-term risks associated with biologic response modifiers used in rheumatic diseases. Curr Opin Rheumatol 16:199\u2013205","journal-title":"Curr Opin Rheumatol."},{"issue":"3","key":"1370_CR7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semarthrit.2006.07.003","volume":"36","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P (2006) Tumor necrosis factor-alpha in inflammatory myopathies, pathophysiology and therapeutic implications. Semin Arthritis Rheum 36(3):168\u2013172","journal-title":"Semin Arthritis Rheum"},{"key":"1370_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000114036","volume":"59","author":"GJD Hengstman","year":"2008","unstructured":"Hengstman GJD, De Bleecker JL, Feist E, Vissing J, Denton CP, Manoussakis MN et al (2008) Open-label trial of anti-TNF-\u03b1 in dermato- and polymyositis treated concomitantly with methotrexate. Eur Neurol 59:159\u2013163","journal-title":"Eur Neurol"},{"key":"1370_CR9","first-page":"1802","volume":"33","author":"F Iannone","year":"2006","unstructured":"Iannone F, Scioscia C, Falappone PC, Covelli M, Lapadula G (2006) Use of etanercept in the treatment of dermatomyositis: a case series. J Rheumatol 33:1802\u20131804","journal-title":"J Rheumatol"},{"key":"1370_CR10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","volume":"67","author":"M Dastmalchi","year":"2008","unstructured":"Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Barbasso Helmers S et al (2008) A high incidence of disease flares in an open pilot study of infliximab in patients with refractory myopathies. Ann Rheum Dis 67:1670\u20131677","journal-title":"Ann Rheum Dis"},{"key":"1370_CR11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.22358","volume":"55","author":"AH Harald","year":"2006","unstructured":"Harald AH, Bernard Z (2006) Evolution of dermatomyositis during therapy with a tumor necrosis factor \u03b1 inhibitor. Arthritis & Rheum 55:982\u2013984","journal-title":"Arthritis & Rheum"},{"key":"1370_CR12","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/keg388","volume":"42","author":"J Musial","year":"2003","unstructured":"Musial J, Undas A, Celinska-Lowenhoff M (2003) Polymyositis associated with infliximab treatment for rheumatoid arthritis. Rheumatology (Oxford) 42:1566\u20131568","journal-title":"Rheumatology (Oxford)"},{"key":"1370_CR13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/s10165-006-0523-1","volume":"16","author":"Y Urata","year":"2006","unstructured":"Urata Y, Wakai Y, Kowatari K (2006) Polymyositis associated with infliximab treatment for rheumatoid arthritis. Mod Rheumatol 16:410\u2013411","journal-title":"Mod Rheumatol"},{"key":"1370_CR14","first-page":"2074","volume":"35","author":"U Kiltz","year":"2008","unstructured":"Kiltz U, Fendler C, Braun J (2008) Neuromuscular involvement in rheumatic patients treated with anti-TNF therapy\u2014three examples. J Rheum 35:2074\u20132075","journal-title":"J Rheum"},{"key":"1370_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/s101650070002","volume":"10","author":"M Hirakata","year":"2000","unstructured":"Hirakata M (2000) Humoral aspects of polymyositis\/dermatomyositis. Mod rheumatol 10:199\u2013206","journal-title":"Mod rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-009-1370-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-009-1370-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:39Z","timestamp":1559105499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-009-1370-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s10067-009-1370-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]}}}